Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN26986053Phase 3Completed
Phase 3, randomised, double-blind trial of nitroglycerin in stroke (2 arms), sponsored by University of Nottingham. Primary endpoint: Modified Rankin Scale at 90 days. Started May 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN26986053.